Reprolife America, LLC – FDA 483, Mar 20, 2026
Reprolife America, LLC in Kingwood, TX, a medical device manufacturer, received a Form FDA 483 with 10 observations during an inspection from March 16-20, 2026. The inspection revealed widespread deficiencies in the firm's quality management system, including a lack of documented procedures for design control, process validation, risk management, complaint handling, traceability, and corrective actions. These systemic failures indicate a significant lack of control over the manufacturing of Vitrification Solution Sets and Warning Solution Sets, potentially impacting product quality and safety.
- Office
- Dallas District Office
- Person
ID · 536ccca4-4bc2-4939-98a3-cfd6228e8cb8
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.